Drug Trial Radar · NCT07457203
Study on the Drug Interaction Between Buagafuran and Voriconazole
Last checked: Nov 19, 2026Latest source record: Mar 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Apr 2026
Primary completion
May 2026
Study completion May 2026
Sponsor
- Lead sponsor
- Beijing Union Pharmaceutical Factory LtdIndustry
- Sponsor type
- Industry
- First posted
- Mar 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is a non-randomized, open label trial aimed at evaluating the drug interaction between Buagafuran capsules and voriconazole tablets in Chinese adult healthy participants.The research period is 7 days in total.
Conditions
- Drug Drug Interaction (DDI)
Interventions
BuagafuranDrug
Buagafuran, oral administration 30mg, signal dose in the morning of day1 and day5
VoriconazoleDrug
Voriconazole tablets, oral administration 400 mg BID on day3, and Voriconazole tablets oral administration 200 mg BID from day4 to day6.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics of Buagafuran( Cmax)Time frame: From day1 to day7
- Pharmacokinetics of Buagafuran (AUC0-inf)Time frame: From day1 to day7
- Pharmacokinetics of Buagafuran (AUC0-t)Time frame: From day1 to day7
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beijing Union Pharmaceutical Factory Ltd
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.